RVTY
Revvity Inc.
NYSE: RVTY · HEALTHCARE · DIAGNOSTICS & RESEARCH
$99.09
+7.36% today
Updated 2026-05-06
Market cap
$9.69B
P/E ratio
42.08
P/S ratio
3.39x
EPS (TTM)
$2.06
Dividend yield
0.32%
52W range
$81 – $118
Volume
1.1M
WallStSmart proprietary scores
63
out of 100
Grade: C+
Hold
Investment rating
4.7
Growth
C5.5
Quality
C+5.5
Profitability
C+6.0
Valuation
B4/9
Piotroski F-Score
Moderate
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →197 stocks currently score above 75
Price targets
Analyst target
$113.93
+14.98%
12-Month target
$61.88
-37.55%
Intrinsic (DCF)
$109.59
Margin of safety
+7.75%
3 Strong Buy7 Buy8 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Free cash flow $163.11M — positive
Risks
- P/E 42.08x — expensive valuation
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $3.31B | $2.75B | $2.76B | $2.86B | $2.86B |
| Net income | $569.18M | $-118.38M | $295.83M | $241.68M | $98.36M |
| EPS | — | — | — | — | $2.06 |
| Free cash flow | $594.18M | $9.90M | $541.65M | $508.25M | $163.11M |
| Profit margin | 17.19% | -4.30% | 10.74% | 8.46% | 8.45% |
Peer comparison
Smart narrative
Revvity Inc. trades at $99.09. representing a P/E of 42.08x trailing earnings. Our Smart Value Score of 63/100 indicates the stock is good. The company scores 4/9 on the Piotroski F-Score. TTM revenue stands at $2.86B. with profit margins at 8.45%. Our DCF model estimates intrinsic value at $109.59.
Frequently asked questions
What is Revvity Inc.'s stock price?
Revvity Inc. (RVTY) trades at $99.09.
Is Revvity Inc. overvalued?
Smart Value Score 63/100 (Grade C+, Hold). DCF value $109.59.
What is the price target of Revvity Inc. (RVTY)?
The analyst target price is $113.93, representing +15.0% upside from the current price of $99.09.
What is the intrinsic value of Revvity Inc. (RVTY)?
Based on our DCF model, intrinsic value is $109.59, a +7.8% margin of safety versus $99.09.
What is Revvity Inc.'s revenue?
TTM revenue is $2.86B.
Piotroski F-Score?
4/9 — moderate financial health.
Company info
SectorHEALTHCARE
IndustryDIAGNOSTICS & RESEARCH
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio3.39x
ROE3.22%
Beta1.13
50D MA$90.32
200D MA$94.36
Shares out0.11B
Float0.10B
Short ratio—
Avg volume1.1M
Performance
1 week-3.74%
1 month-14.66%
3 months-13.60%
YTD-13.28%
1 year—
3 years—
5 years—